CDC touts folic acid
This article was originally published in The Tan Sheet
Executive Summary
More women regularly used folic acid supplements in 2007 than in previous years, yet the majority of women still do not take the recommended 400 mg daily amount, according to a Centers for Disease Control and Prevention study in the Jan. 11 Morbidity and Mortality Weekly Report. Roughly 40 percent of women surveyed in 2007 said they took a supplement with folic acid daily, compared with 33 percent in 2005 and 32 percent in 2003. CDC urges folic acid use among more 18-to 24-year-old women because only 6 percent knew when to take the supplement, and only 61 percent were aware of folic acid consumption in general...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.